05.12.10
A recent clinical trial has shown geniVida from DSM Nutritional Products significantly increased bone mineral density by up to 3.4% in post-menopausal women after six months of supplementation. Data was presented at the IOF World Congress on Osteoporosis in May.
Conducted in collaboration with Creighton University, Omaha, NE, this pilot, randomized, placebo-controlled, double-blind study involved 58 healthy, early post-menopausal women. The geniVida Bone Blend is a patented combination of geniVida brand pure genistein, ROPUFA brand omega 3 fatty acids EPA and DHA and the vitamins Quali-D D3 and Quali-K K1.
“The new study provides evidence of the significant health benefits offered by a multi-nutrient solution to a multifactorial health issue such as bone mineral density,” said William Black, vice president of New Nutritional Ingredients at DSM. For further information: www.dsmnutritionalproducts.com
Conducted in collaboration with Creighton University, Omaha, NE, this pilot, randomized, placebo-controlled, double-blind study involved 58 healthy, early post-menopausal women. The geniVida Bone Blend is a patented combination of geniVida brand pure genistein, ROPUFA brand omega 3 fatty acids EPA and DHA and the vitamins Quali-D D3 and Quali-K K1.
“The new study provides evidence of the significant health benefits offered by a multi-nutrient solution to a multifactorial health issue such as bone mineral density,” said William Black, vice president of New Nutritional Ingredients at DSM. For further information: www.dsmnutritionalproducts.com